Serologic evaluation of Hepatitis B vaccination (Infanrix hexa)

Serologic evaluation of Hepatitis B vaccination (Infanrix hexa) - Infanrix hexa evaluation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON31015

Enrollment

300

Registered

2007-11-27

Start date

2009-05-10

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

immunological response antibodies

Interventions

None listed

Eligibility

Age

2 Years to 11 Years

Inclusion criteria

Inclusion criteria: Children vaccinated with the combination vaccin Infanrix hexa, of which hepatitis B is a part

Exclusion criteria

Exclusion criteria: Children not vaccinated with the combination vaccine Infanrix hexa and children born to women with hepatitis B infection will be excluded.

Design outcomes

Primary

Measure	Time frame
- proportion of participants with a anti-Hbs titer	—

Secondary

Measure	Time frame
- anti-Hib, pneumococcen, pertussis titers - response with regard to questions regarding acceptability of HBV vaccination	—

Countries

Netherlands

Outcome results